Skip to main content
PLOS One logoLink to PLOS One
. 2022 Mar 11;17(3):e0264777. doi: 10.1371/journal.pone.0264777

Characteristics, experiences and actions taken by women to address delayed conception: A mixed-methods cross-sectional study protocol

Priyanka Adhikary 1, Nivedita Roy 1, Gitau Mburu 2, Rita Kabra 2, Ndema Abu Habib 2, James Kiarie 2, Neeta Dhabhai 1, Ranadip Chowdhury 1, Sarmila Mazumder 1,*
Editor: José Antonio Ortega3
PMCID: PMC8916660  PMID: 35275948

Abstract

Background

The impact of infertility on mental, emotional, physical and sexual health is grave, particularly in a pronatalist society. Literature is replete with evidence of wide ranging psychosocial consequences of infertility in women, indicating the need for identifying the gaps and designing appropriate context specific interventions to improve access and utilization of services. Data that are accessible, primarily from infertility clinics and women visiting hospitals for infertility treatment; information from community settings is rare. This is a protocol paper for a study to understand women’s experiences and actions taken by them to cope with delayed conception.

Methods

Mixed-methods cross-sectional design is used to obtain deep insights into the experiences of delayed conception, coping mechanisms, medical assistance and other help sought. Information is also being obtained on socio-demographic profile, fertility intentions, fertility quality of life, general medical history, obstetric, gynecological and sexual history, substance use and mental health status. A sample of 1530 women will be administered 4 modules of a quantitative survey. Focus group discussions, about four or till saturation point, will be conducted using purposive sampling. The study is recruiting from a population of women who previously participated in the ‘Women and Infants Integrated Interventions for Growth Study (WINGS) and failed to conceive during 18 months follow up period. Data collected through questionnaire will be assembled, cleaned, analyzed and reported. The findings will be disseminated through reports with the ethics review committee, government entities, academic and research publications.

Discussion

This study will provide insights on the experiences and coping strategies of women with delayed conception in the study community. Results will assist in designing appropriate interventions to meet the holistic health and psychosocial needs of women with delayed conception and promote sexual and reproductive health within the broader framework of Sustainable Development Goals and Universal health coverage.

Trial registration

Trial registration number: CTRI/2020/03/023955.

Background

The World Health Organization defines infertility as a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse [1]. Globally, up to 16.7% of couples of reproductive age experience difficulties in conceiving [2, 3] and in India, it varies between 3.9 to 16.8% [4, 5]. Infertility or delayed conception has important impact on mental, emotional physical and sexual health, particularly in settings where bearing a child holds high value. In these settings, the ability to bear a biological child is considered an indication of a woman’s health, and her position in society [6].

Literature is replete with evidence that infertility is associated with a wide-range of psychosocial consequences in women, including poor quality of life and marital relationships, depression, anxiety, decreased self-esteem, victims of violence, irrational thoughts, feelings of apprehensions and rejection, social stigma, somatization disorders, sexual dysfunction, and many more [612]. Significant association of psychosocial wellbeing has been found with age, occupation, education, and lack of social support [13, 14]. However, a majority of the existing studies are mostly from infertility clinics and hospital settings, where women seek care for infertility treatment. Studies from the community are rare.

An interesting paradox from global literature is that while childbearing is seen as important, 40–50% of infertile women in several studies did not seek help, often due to lack of cognitive awareness of the problem, or absence of symptom perception [15, 16]. Furthermore, in many low-and middle-income countries, infertility may not be recognized as a serious health problem that requires a combination of medical and psychological management [17]. Sub-optimal help seeking behavior is also frequently affected by prevailing attitudes towards informal and formal sources of fertility help [1820] including costs associated with such help [16]. For instance, medical treatments such as assisted reproductive technologies are often unaffordable [21, 22]. Evidence from other settings suggest that medical treatment is the last resort, as women often first seek alternative treatment such as herbalists, spiritualists, and religious leaders as these are culturally more acceptable [2123]. To date however, relatively limited research has examined how women cope with infertility in India [24, 25].

Understanding how many women experience infertility and how they cope with their circumstances is an essential first step towards providing them with necessary supportive interventions. Likewise, understanding household out-of-pocket expenditures that women and couples spend in their quest to conceive is important in formulating the kind of subsidies that can be provided to such families in the context of fertility care services. In India, there is limited access to fertility and assisted reproduction services [26].

The present study, therefore, aims to describe the sociodemographic and other baseline characteristics of women who experience delayed conception, their perspectives, actions and experiences related to delay in conceiving, their quality of life and mental health and the costs of any interventions received.

Methods

Study design

This is a cross-sectional mixed methods study combining both quantitative and qualitative research methods. Close-ended objective questionnaire for the quantitative component and focus group discussions (FGDs) guide, for the qualitative component, are used for data collection.

Study participants

Study participants are being recruited from a population of women who previously participated in the ‘Women and Infants Integrated Interventions for Growth Study (WINGS) and did not become pregnant during the 18 months follow up period. WINGS is being conducted in the urban low-middle income neighborhood located in the South district of Delhi [27]. The purpose of WINGS is to enable women of reproductive age to enter pregnancy in good health, free of sexually transmitted infections (STIs), and well-nourished, through the implementation of an intervention package comprising nutrition, health, WASH and psychosocial care. The current study is an independent study where women are being recruited after they exit from WINGS. Based on current definitions, women of reproductive age (15–49 years) at risk of becoming pregnant (not pregnant, sexually active, not using contraception and not lactating) who report trying unsuccessfully for pregnancy for one year or more are classified as clinically infertile [28].

Ethics approval and consent to participate

Approval for this study (Protocol version: 4.0 dated October 19, 2020) has been obtained from the Ethics Review Committee of the Centre for Health Research and Development, Society for Applied Studies (Approval number- SAS/ERC/RHR-Infertility/2020, approval date- January 9, 2020) and the World Health Organization, Geneva (Approval number- A-ID: A65998, approval date: February 13, 2020).

At the time of obtaining written informed consent, the research assistants, provide detail information about the new study. Women are asked questions to confirm that their participation in WINGS was completed at least 14 days earlier, their intention to become pregnant during their participation and after their exit in WINGS, and their interest to participate in the study on delay in conceiving. To ensure that women are not be under duress to consent to this study, clear statements are made to explain to the women that their participation is not obligatory, and enrolment is entirely voluntary. The study team comprises of well-trained personnel, with the required experience and expertise. In addition, the study team is trained in Good Clinical Practice and how to appropriately administer the consent form. The research assistant checks that all participants understand the above. At exit from WINGS, the WINGS study team seeks permission from the WINGS participants to share their contact details with the study team of the infertility study. If the participants give consent, only then the infertility study team visits the women at least 14 days after their exit from WINGS, to introduce the study. Written individual informed consent is obtained during participants’ enrolment. Consent is obtained for quantitative data collection and for FGDs. For those who are unable to read, the consent form is read out by the worker obtaining consent. In those who are unable to sign, a thumb imprint is taken which is witnessed (counter signed) by an impartial literate witness. The informed consent form is translated into simple Hindi language that can be easily read and understood.

The information collected from the study participants is kept confidential. The participants are not identified by her name but only by a study number. All information collected is stored in a locked area with access only to the study team. All study documents are be stored for a period of 5 years and will be destroyed at the end of the 5 years. The knowledge which we get from doing this research study will be shared through reports given to the ethics review committee, government agencies and publications but none will have the name of the study participants. No personally identifiable data is collected in this study. Only the unique study codes allocated to participants at enrolment are used in the questionnaires and focus group discussions. All data will have been aggregated before reporting. Furthermore, data is stored in-country by SAS and only reviewed by the immediate research team. All study team members are trained in Good Clinical Practice and are well versed with the principles of ethics. Women’s autonomy is of prime importance, and we ensure that this is respected.

Women are provided with a small token of appreciation not exceeding 1.5 USD, alongside a free counseling on infertility. It is considered reasonable to compensate participants for their time and not an inducement.

This study enrolls women who had participated in WINGS, which has a large component of community participation. A significant part of contacts with participants is conducted at their homes, and local communities are continually reached and mobilized with the results to enhance uptake of interventions that promote better infant outcomes.

Participant recruitment

At the time of exit from WINGS, consent for sharing the contact details of women with the new study team is sought, mentioning that this is a separate study and not a part of WINGS. If women agree with sharing of their contact details, the new study team, which is a separate team from WINGS, contacts these women at least 14 days after their exit from WINGS, to introduce the study. Women are contacted consecutively by field workers according to their exit dates, based on completion of 18 months’ post-enrolment without getting pregnant. Women who agree to participate are invited to participate in the current study and at this point, written informed consent form is administered.

The study team screens women for eligibility. Women with delayed conception, living with husband, wishing to conceive and have not been using any form of contraceptives, are eligible to be enrolled (Fig 1).

Fig 1. Overview of the study design.

Fig 1

Sample size

For the purpose of the quantitative component of the study, the minimum sample size needed to estimate infertility or delayed conception, with 2% absolute precision and 95% CI from this sample would be 1223, assuming a prevalence of 17% as reported in the literature [4, 5], and a finite population of 12,500. An allowance of 25% for non-responses has been made. Final sample size is therefore 1530. The study enrolment will continue on a consecutive basis until the required 1530 women who did not become pregnant at 18 months are interviewed.

A purposive sampling is drawn to conduct FGD from women who participate in the quantitative survey. Recruitment will be informed by saturation of data, or to a maximum of 50 participants, approximately 4 sessions of 10–15 participants each. Data will reach a saturation point when no new information will be generated during the FGDs and further data collection will not yield additional findings. FGD audio recordings will be used to assess whether the FGDs no longer bring out any new information or knowledge to confirm data saturation. The intent in purposive sampling is to obtain a representative of the sample of a more homogenous group (experienced primary or secondary infertility or delayed conception) than the total population.

Survey procedure

Once informed written consent is obtained, face-to-face interviews are conducted with the women, using a standardized survey questionnaire. The questionnaire comprises the following four modules/sections:

Module 1 comprises 20 background questions on social demographic variables and fertility intentions. These questions have been adopted from previous surveys and studies related to infertility. They capture information related to age of partners, duration of infertility and employment among others.

Module 2 comprises the Fertility Quality of Life (FertiQoL) questionnaire (English and a translated Hindi version). The FertiQoL questionnaire is a validated instrument developed by an international collaboration of experts, for specifically assessing quality of life in all people experiencing fertility problems [29]. As opposed to generic measure of quality of life, it is validated and specific to infertility (www.fertiqol.org). FertiQoL assesses the impact of infertility on four domains that is Mind-Body (six items), Relational (six items), Social (six items) and Emotional (six items). It assesses these impacts on different formats of a five-point Likert scale: (i) from very poor to very good (one item); (ii) from very dissatisfied to very satisfied (seven items); (iii) from completely to not at all (four items); (iv) from always to never (eight items) and (v) from an extreme amount, to not at all (six items). FertiQoL comprises two modules: a core-FertiQoL module and an (optional) treatment-module. For this study the treatment module was excluded as the study was not formally providing treatment for infertility or delayed conception. This is particularly salient given the emphasis by researchers regarding the importance of making use of non-clinic-based samples to better understand the experience of infertility [30]. The final FertiQoL versions, including the Hindi version used in this study have all been professionally translated and checked by fertility experts to ensure appropriateness of wording to local customs and usage, including in India.

Module 3 comprises 13 questions on actions taken including help seeking. Actions taken by women are assessed in three key domains: the first is help seeking, using format adapted from the General Help Seeking Questionnaire (GHSQ) [31]. The GHSQ was originally developed to assess future help seeking from a list of culturally-relevant sources [31], but may be used to identify actual help seeking. The sources of help included in the GHSQ are classified into two major classes: formal (such as doctors, traditional and faith healers), and informal (such as parents, friends, a partner or other relatives). We adapted the GHSQ to ask about actual (rather than intended) behaviors, and adapted the sources as locally relevant, and collapsed the response categories to YES/NO as have been done in other studies [32]. We also include a category “did not seek help” so that we can identify participants that did not seek help. The second domain to be assessed regarding women’s action is their out of pocket expenditure on the above sources of help by asking women to estimate the amounts of money they spent on each of the above sources of help (which may or may not be catastrophic). To assess barrier to access to care, the questionnaire assess the importance of 24 barriers to access to care items validated from other studies [33], which were piloted and modified based locally relevant barriers. Finally, the survey collects data on adoption of practices such as vaginal douching, use of traditional remedies, seeking, medical assistance, or other changes in sexual behavior and limited information on action taken by husbands, care seeking by husbands, or any sexual problem faced by husbands.

Module 4 comprises questions exploring general medical history including obstetric, gynecological, sexual, substance use and mental health. The module collects data on social demographic variables, history of hormonal or other co-morbidities, detailed menstrual cycle history, abortions, whether spontaneous or medically terminated, STI and sexual behavior, alcoholism, and smoking. A validated 4-item Patient Health Questionnaire-4 (PHQ-4) is used to assess mental health (depression and anxiety). PHQ-4 is an ultra-brief self-report questionnaire that consists of a 2-item depression scale (PHQ-2) and a 2-item anxiety scale (GAD-2) [34].

It takes 1.5 to 2 hours to respond to all the four modules, constituting an estimated 100 questions. During piloting the study team had assessed the necessity to conduct the interviews in more than 2 rounds/sessions, for example if these questions are overwhelming, or if the time required responding is too long. Piloting of the questionnaire also assessed the interpretation and use of alternative terms to infertility, such as “difficulties in conceiving”, “delay in conceiving”, or “failure to conceive” to ensure relevance and cultural sensitivity.

Risk of infertility is increased due to STI. STI symptoms are identified as part of the questionnaire under the sexual health section. Study participants identified with symptoms of vaginal discharge are examined at the study clinic by study physician (MD Obstetrics and Gynaecology), and provided treatment free of cost, based on the syndromic approach, as recommended in the Government of India guidelines. If required, referral of the participant and/or her husband, to the collaborating tertiary care hospital, Safdarjung hospital, is facilitated by the study team, for further evaluation and management. Regular infertility clinics are conducted in the hospital. Investigations and treatment are free of cost in the collaborating hospital. Transportation arrangements are made by the study team.

At the end of questionnaire administration, women are offered free counselling regarding their delay in conceiving by the gynaecologist and obstetrician. If the women want, they are also referred to the infertility clinic at Safdarjung hospital. For any emotional distress pertaining to infertility, the study psychologist conduct free counselling sessions with the woman, her husband and other family members. The study team may become aware of interpersonal violence from their partners/husbands. The study does not provide direct intervention in matters of domestic violence or abuse, which may worsen the situation further. We have identified organizations locally that offer help and support to women who are victims of domestic and intimate partner violence/abuse. If women are comfortable and willing to seek such help, they are provided with the linkages and offered assistance, in terms of transportation to access these services.

Women responding to the quantitative questionnaire are informed and invited to participate in FGDs and based on their interest and availability, included in the FGDs. This is a purposive sample drawn from women who participate in the survey. These FGDs provide in-depth information regarding women’s and to some limited extent, their husbands’ perceptions, experiences, actions and motivations for such actions, while contextualizing the quantitative data. The use of qualitative methods in exploring experiences of infertility is critical given that infertility is a socially constructed phenomenon [35].

FGDs are guided by topic guide covering a range of topics such as experiences of delayed conception, coping with delayed conception, vaginal douching, traditional remedies, help seeking, including specialized medical assistance, and other actions. A field trial of the FGD topic guide was conducted on a small sample of women (n = 6) and revisions were made based on feedback to ensure relevance and cultural sensitivity. FGDs are conducted following the questionnaire, in a QUANT-QUAL sequence [36]. FGDs are audio recorded and held at a WINGS site in local language. These last for 45–60 minutes.

Data analysis

The quantitative data will be assessed for completeness and cleaned. To meet objective 1, characteristics of women participate in this study and who exit the WINGS at 18 months without becoming pregnant will be described using descriptive statistics. These characteristics include social demographic, gynecological, obstetric, family, mental health and substance use as described in the questionnaire. To meet objective 2, on quality of life of women participating in this sub-study, scores of FertQual questionnaire will be derived.

Overall scores and sub-scores will be calculated for both the FertiQoL following the established scoring criteria for each questionnaire. FertiQoL will be scored to derive mean values (a value of 0 indicates the most negative answer and a value of 4 indicates most positive). The scores for each question will be from very poor (= 0) to very good (= 4), from very dissatisfied (= 0) to very satisfied (= 4), from completely (= 0) to not at all (= 4), from always (= 0) to never (= 4) and from an extreme amount (= 0) to not at all (= 4). After that, the interpretation of FertiQoL total and subscale scores will range from 0to 100. The consistency of FertiQoL questionnaire will be assessed by computing a Cronbach’s α coefficient of these scales. Means, standard deviations (SDs) and proportions will be calculated, and parametric tests were used on variables for medical history in the study.

Actions and barriers to seeking help will be analyzed by deriving proportions of women who report specific barriers. Exploratory analysis will be conducted to analyze predictors of help seeking. These will be complemented with mental health scores from PHQ4. Assessments of depression and anxiety will be conducted by assessing participants’ responses to the questions, “over the last 2 weeks, how often have you had “little interest or pleasure in doing things” and “over the last 2 weeks, how often have you been “feeling down, depressed, or hopeless” and ‘over the feeling nervous, anxious or on edge”, “over the last 2 weeks, how often have you “not being able to stop or control worrying?” Participants will be required to select/check only one answer from four options i.e., “not at all”, “several days”, “more than half the days or nearly every day.”

Experiences and actions taken by women will be described using data from both the quantitative survey and the qualitative FGDs. These will include experiences of violence, stigma, divorce, separation as well as help-seeking and the cost of assistance sought in relation to infertility. Qualitative analysis will document information related to experiences and subsequent actions of delayed conception, coping with delayed conception, vaginal douching, traditional remedies, help seeking (from traditional, family, religious, or medical sources) as well as and socio-economic impacts of delayed conception.

Qualitative analysis will be conducted via an inductive process [37] in which nodes and codes will be developed in Nvivo [38] and semantic themes derived based on most commonly occurring phenomena, related to women’s experiences and actions and motivations for those actions.

Interpretative stance will be assumed, and an intersectionality approach will be used to elaborate ways in which both gender and other axes of social locations intersect to determine experiences of women, and how differential and dynamic experiences may occur based on the varying nature of participants social, economic or positions in society. Given that gender roles has an impact on women’s experiences of infertility in Asia [39], it is expected that intersectionality would be useful in explaining varying ways in which gender intersects with other axes, such as economic deprivation- to produce different experiences among women [39]. To elaborate specifically on the actions that women take, the theory of planned behavior, which is an extension of the Theory of Reasoned Action [40] will be drawn upon. The use of these two theoretical frameworks will add credibility and rigor to the analysis. Following the development of descriptive themes, analytical themes will then be derived with reference to the literature and the study context. Further hypothesis may be developed following the above exploratory analysis.

Discussion

This study aims to better understand the sexual and reproductive contexts of women through exploring the characteristics, psychosocial impact and actions taken by women with delay in conceiving. Infertility has been widely studied from clinical perspective but due to the sensitive nature of the topic, previous studies failed to capture accurate and relevant information about the effect of infertility on marital and sexual life in India [41]. There is also a dearth of community based studies, most of the literature reporting the negative impact of infertility on mental health and quality of life, are from hospital settings and include women who actively seek care. The present study enrolls women from the community, including those women who may not have sought help. Additionally, the familiar home environment allows women to be comfortable and feel free to share their perspectives and experiences.

Apart from assessing the quality of life, psycho-social impact of infertility, and actions taken by women if any, when conception is delayed, this study will provide useful information on potential barriers in accessing appropriate care, assess the need for intervention, and identify potential interventions. The FGDs will play a pivotal role in encouraging women to express their feelings, experiences and distress and provide a platform for sharing and interacting with others, thus providing deep insights and identify the need for urgent action, with suitable interventions, including social support.

This study does not involve the husbands and other family members of the participants or the health care providers in the area catering to problems related to delayed conception, hence may miss relevant additional perspectives and information which may be useful in further contextualizing the findings. This study samples participants from a population of women who previously participated in a study in Northern part of India, which may limit generalizability.

Conclusion

This study will contribute to better understanding of the characteristics, experiences, and coping strategies of women with delayed conception in the study community. Results will assist in designing appropriate interventions to meet the holistic health and psychosocial needs of women with delayed conception and promote sexual and reproductive health within the broader framework of Sustainable Development Goals, and universal health coverage. The dissemination of study findings will be done through presentations and publications at scientific meetings and conferences, and peer reviewed journals respectively. The results will also be shared with relevant professional bodies and non-governmental organizations at national and sub-national levels.

Supporting information

S1 File. CHRD SAS ERC infertility approval letter.

(PDF)

S2 File. WHO ERC infertility approval letter.

(PDF)

S3 File. Consent form.

(PDF)

S1 Questionnaire. Questionnaire modules.

(PDF)

S1 Checklist. SPIRIT 2013 checklist: Recommended items to address in a clinical trial protocol and related documents*.

(DOC)

Acknowledgments

The authors are thankful to the implementation partners of WINGS including CHRD-SAS, Safdarjung Hospital, and the Department of Maternal, Newborn, Child and Adolescent Health, WHO. The authors also extend their gratitude to the participants of the study. The views expressed are those of the authors and not necessarily those of their respective institutions.

Abbreviations

FGD

Focus-Group Discussion

WINGS

Women and Infant Integrated Interventions for Growth Study

FertiQo

Fertility Quality of Life

GHSQ

General Help Seeking Behavior

PHQ

Patient Health Questionnaire

QUANT-QUAL

Quantitative-Qualitative

STI

Sexually Transmitted Infections

Funding Statement

Grant awarded to SM Grant number-2020/1026382-0 Funder-World Health Organization URL of the funder website-https://www.who.int/ The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization (WHO) International Classification of Diseases, 11 Revision (ICD-11) Geneva: WHO. 2018. Available from Eleventh revision of the International Classification of Diseases (who.int).
  • 2.Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. PLoS Med. 2012;9(12):e1001356. doi: 10.1371/journal.pmed.1001356 Available from National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys (plos.org) . pmed.1001356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Human reproduction (Oxford, England). 2007;22(6):1506–12. Epub 2007/03/23. doi: 10.1093/humrep/dem046 Available from International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care—PubMed (nih.gov) . [DOI] [PubMed] [Google Scholar]
  • 4.Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries: ORC Macro, MEASURE DHS; 2004. Microsoft Word—Infecundity_Report KS.doc (dhsprogram.com).
  • 5.Adamson PC, Krupp K, Freeman AH, Klausner JD, Reingold AL, Madhivanan P. Prevalence & correlates of primary infertility among young women in Mysore, India. Indian J Med Res 2011;134(4):440–6. Available from Prevalence & correlates of primary infertility among young women in Mysore, India (nih.gov) ; PMCID: PMC3237240. [PMC free article] [PubMed] [Google Scholar]
  • 6.Sharma RS, Saxena R, Singh R. Infertility & assisted reproduction: A historical & modern scientific perspective. Indian J Med Res. 2018;148(Suppl):S10–s4. Epub 2019/04/10. doi: 10.4103/ijmr.IJMR_636_18 Available from Infertility & assisted reproduction: A historical & modern scientific perspective (nih.gov) ; PubMed Central PMCID: PMC6469376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zarif Golbar Yazdi H, Aghamohammadian Sharbaf H, Kareshki H, Amirian M. Psychosocial Consequences of Female Infertility in Iran: A Meta-Analysis. Front Psychiatry. 2020;11:518961-. doi: 10.3389/fpsyt.2020.518961 Available from Psychosocial Consequences of Female Infertility in Iran: A Meta-Analysis (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sherina MS, Rampal L, Mustaqim A. The prevalence of depression among the elderly in Sepang, Selangor. Med J Malaysia. 2004;59(1):45–9. Epub 2004/11/13. Available from The prevalence of depression among the elderly in Sepang, Selangor—PubMed (nih.gov) . [PubMed] [Google Scholar]
  • 9.Saleem S, Shaheen A, Jabeen A, Mahmood Z. Psychosocial Issues in Women with Primary Infertility: A Psychometric Study. Annals of King Edward Medical University. 2021;27(1):37–42. Available from Psychosocial Issues in Women with Primary Infertility: A Psychometric Study | Annals of King Edward Medical University (annalskemu.org). [Google Scholar]
  • 10.Patel A, Sharma P, Kumar P, Binu V. Sociocultural determinants of infertility stress in patients undergoing fertility treatments. J Hum Reprod Sci. 2018;11(2):172–179. doi: 10.4103/jhrs.JHRS_134_17 Available from Sociocultural Determinants of Infertility Stress in Patients Undergoing Fertility Treatments (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bondade S, Iyengar RS, Shivakumar B, Karthik K. Intimate partner violence and psychiatric comorbidity in infertile women-A cross-sectional hospital based study. Indian J Psychol Med. 2018;40(6):540–546. doi: 10.4103/IJPSYM.IJPSYM_158_18 Available from Intimate Partner Violence and Psychiatric Comorbidity in Infertile Women–A Cross-Sectional Hospital Based Study (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Szkodziak F, Krzyżanowski J, Szkodziak P. Psychological aspects of infertility. A systematic review. J Int Med Res. 2020. Jun;48(6):300060520932403. doi: 10.1177/0300060520932403 Available from Psychological aspects of infertility. A systematic review (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Khosla P, Tripathy P, Nayak D. PSYCHOSOCIAL WELLBEING AMONG PRIMARY INFERTILE WOMENATTENDING INFERTILITY CLINIC. Available from pdf_7262_c195e71f49ca79865d1a9cf45a0f6b05.html (ejmcm.com) Eur J Mol Clin Med. 2021;7(11):5124–5129.
  • 14.Iordachescu DA, Gica C, Vladislav EO, Panaitescu AM, Peltecu G, Furtuna ME, et al. Emotional disorders, marital adaptation and the moderating role of social support for couples under treatment for infertility. Ginekol Pol. 2021;92(2):98–104. Epub 2021/01/16. doi: 10.5603/GP.a2020.0173 Available from Emotional disorders, marital adaptation and the moderating role of social support for couples under treatment for infertility | Iordachescu | Ginekologia Polska (viamedica.pl) . [DOI] [PubMed] [Google Scholar]
  • 15.White L, McQuillan J, Greil AL, Johnson DR. Infertility: testing a helpseeking model. Soc Sci Med. 2006; 62(4):1031–1041. doi: 10.1016/j.socscimed.2005.11.012 Epub 2005/12/19. Available from Infertility: Testing a helpseeking model–ScienceDirect . [DOI] [PubMed] [Google Scholar]
  • 16.Bunting L, Boivin J. Decision-making about seeking medical advice in an internet sample of women trying to get pregnant. Hum Reprod. 2007;22(6):1662–1668. doi: 10.1093/humrep/dem057 Available from Decision-making about seeking medical advice in an internet sample of women trying to get pregnant | Human Reproduction | Oxford Academic (oup.com). [DOI] [PubMed] [Google Scholar]
  • 17.Naab F, Brown R, Ward EC. Culturally adapted depression intervention to manage depression among women with infertility in Ghana. J Health Psychol. 2021;26(7):949–961. doi: 10.1177/1359105319857175 Epub 2019/07/20. Available from Culturally adapted depression intervention to manage depression among women with infertility in Ghana—PubMed (nih.gov) . [DOI] [PubMed] [Google Scholar]
  • 18.Bunting L, Tsibulsky I, Boivin J. Fertility knowledge and beliefs about fertility treatment: findings from the International Fertility Decision-making Study. Hum Reprod. 2013;28(2):385–397. doi: 10.1093/humrep/des402 Epub 2012/11/25. AVailable from Fertility knowledge and beliefs about fertility treatment: findings from the International Fertility Decision-making Study | Human Reproduction | Oxford Academic (oup.com) . [DOI] [PubMed] [Google Scholar]
  • 19.Masoumi SZ, Parsa P, Kalhori F, Mohagheghi H, Mohammadi Y. What psychiatric interventions are used for anxiety disorders in infertile couples? A systematic review study. Iran J Psychiatry. 2019; 14(2):160–170. Available from What Psychiatric Interventions Are Used for Anxiety Disorders in Infertile Couples? A Systematic Review Study (nih.gov) . [PMC free article] [PubMed] [Google Scholar]
  • 20.Parry DC. Work, leisure, and support groups: An examination of the ways women with infertility respond to pronatalist ideology. Sex Roles. 2005;53(5):337–346. doi: 10.1007/s11199-005-6757-0 Available from Work, Leisure, and Support Groups: An Examination of the Ways Women with Infertility Respond to Pronatalist Ideology | SpringerLink. [DOI] [Google Scholar]
  • 21.Nachtigall RD. International disparities in access to infertility services. Fertil Steril. 2006;85(4):871–875. doi: 10.1016/j.fertnstert.2005.08.066 Available from International disparities in access to infertility services—Fertility and Sterility (fertstert.org) . [DOI] [PubMed] [Google Scholar]
  • 22.Dutney A. Religion, infertility and assisted reproductive technology. Obstet Gynaecol. 2007. Feb;21(1):169–180. doi: 10.1016/j.bpobgyn.2006.09.007. Epub 2006/11/18. Available from Religion, infertility and assisted reproductive technology—ScienceDirect . [DOI] [PubMed] [Google Scholar]
  • 23.Steenkamp V. Traditional herbal remedies used by South African women for gynaecological complaints. J Ethnopharmacol. 2003;86(1):97–108. doi: 10.1016/s0378-8741(03)00053-9 Available from Traditional herbal remedies used by South African women for gynaecological complaints—ScienceDirect . [DOI] [PubMed] [Google Scholar]
  • 24.Patra S, Unisa S. Addressing reproductive health knowledge, infertility and coping strategies among rural women in India. Biosoc Sci. 2021;53(4):557–565. doi: 10.1017/S0021932020000371 Epub 2020 Jul 17. Available from Addressing reproductive health knowledge, infertility and coping strategies among rural women in India | Journal of Biosocial Science | Cambridge Core . [DOI] [PubMed] [Google Scholar]
  • 25.Roberts L, Renati S, Solomon S, Montgomery S. Women and Infertility in a Pronatalist Culture: Mental Health in the Slums of Mumbai. Int J Womens Health. 2020;12: 993–1003. doi: 10.2147/IJWH.S273149 Available from Women and Infertility in a Pronatalist Culture: Mental Health in the Slums of Mumbai (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Widge A. Sociocultural attitudes towards infertility and assisted reproduction in India. In: Vayena E, Rowe PJ, David Griffin P, editors. Current practices and controversies in assisted reproduction, 2002;60:74. Available from Sociocultural attitudes towards infertility and assisted reproduction in India—National Library of Medicine Institution (nih.gov). [Google Scholar]
  • 27.Taneja S, Chowdhury R, Dhabhai N, Mazumder S, Upadhyay RP, Sharma S, et al. Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre-and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India. Trials. 2020. 31;21(1):127. doi: 10.1186/s13063-020-4059-z Available from Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al.; The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Human Reprod. 2009;24(11):2683–2687. doi: 10.1093/humrep/dep343 Available from International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009† | Human Reproduction | Oxford Academic (oup.com). [DOI] [PubMed] [Google Scholar]
  • 29.Boivin J, Takefman J, Braverman A. The fertility quality of life (FertiQoL) tool: development and general psychometric properties. Human Reprod. 2011;26(8):2084–2091. Available from The fertility quality of life (FertiQoL) tool: development and general psychometric properties (nih.gov) doi: 10.1093/humrep/der171 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Greil AL, Slauson-Blevins K, McQuillan J. The experience of infertility: a review of recent literature. Sociol Health Illn. 2010. Jan;32(1):140–162. doi: 10.1111/j.1467-9566.2009.01213.x Epub 2009/12/ 9. Available from The experience of infertility: A review of recent literature (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wilson CJ, Deane FP, Ciarrochi JV, Rickwood D. Measuring help seeking intentions: properties of the general help seeking questionnaire. Can J Couns. 2005;39(1):15–28.Available from Measuring help seeking intentions: Properties of the General Help Seeking Questionnaire (uow.edu.au). [Google Scholar]
  • 32.Azale T, Fekadu A, Hanlon C. Treatment gap and help-seeking for postpartum depression in a rural African setting. BMC psychiatry. 2016;16(1):1–10. doi: 10.1186/s12888-016-0892-8 Available from Treatment gap and help-seeking for postpartum depression in a rural African setting | BMC Psychiatry | Full Text (biomedcentral.com). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Clement S, Brohan E, Jeffery D, Henderson C, Hatch SL, Thornicroft G. Development and psychometric properties the Barriers to Access to Care Evaluation scale (BACE) related to people with mental ill health. BMC psychiatry. 2012;12:36. doi: 10.1186/1471-244X-12-36 Available from Development and psychometric properties the Barriers to Access to Care Evaluation scale (BACE) related to people with mental ill health | BMC Psychiatry | Full Text (biomedcentral.com) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95. doi: 10.1016/j.jad.2009.06.019 Epub 2009/07/17. Available from A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population—ScienceDirect . [DOI] [PubMed] [Google Scholar]
  • 35.Greil AL. Infertility and psychological distress: a critical review of the literature. Soc Sci Med. 1997;45(11):1679–704. doi: 10.1016/s0277-9536(97)00102-0 Available from Infertility and psychological distress: A critical review of the literature—ScienceDirect [DOI] [PubMed] [Google Scholar]
  • 36.Giddings LS, Grant BM. Mixed methods research for the novice researcher. Contemp Nurse. 2006;23(1):3–11. doi: 10.5172/conu.2006.23.1.3 Available from (PDF) Mixed methods research for the novice researcher (researchgate.net) . [DOI] [PubMed] [Google Scholar]
  • 37.Braun V, Clarke V. Using thematic analysis in psychology. Qual research psychology. 2006;3(2):77–101. doi: 10.1191/1478088706qp063oa Available from (PDF) Using thematic analysis in psychology (researchgate.net). 32100154 [DOI] [Google Scholar]
  • 38.Richards L. Using NVivo in qualitative research. Sage publications; 1999. Available from Using NVIVO in Qualitative Research—Lyn Richards—Google Books.
  • 39.Mumtaz Z, Shahid U, Levay A. Understanding the impact of gendered roles on the experiences of infertility amongst men and women in Punjab. Reprod Health. 2013, 15;10:3. doi: 10.1186/1742-4755-10-3 Available from Understanding the impact of gendered roles on the experiences of infertility amongst men and women in Punjab (nih.gov) . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ajzen I, Klobas J. Fertility intentions: An approach based on the theory of planned behavior. Demographic Res. 2013;29:203–232. doi: 10.4054/DemRes.2013.29.8 Available from Fertility intentions: An approach based on the theory of planned behavior (Volume 29—Article 8 | Pages 203–232) (demographic-research.org). [DOI] [Google Scholar]
  • 41.Valsangkar S, Bodhare T, Bele S, Sai S. An evaluation of the effect of infertility on marital, sexual satisfaction indices and health-related quality of life in women. Hum Reprod Sci. 2011;4(2):80–5. doi: 10.4103/0974-1208.86088 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

José Antonio Ortega

27 Jan 2022

PONE-D-21-37261Characteristics, experiences and actions taken by women to address delayed conception: A mixed-methods cross-sectional study protocolPLOS ONE

Dear Dr. Mazumder,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Two reviewers have gone through the manuscript finding that it is amenable for publication with minor revisions and including more information, in particular the questionnaire.

Please submit your revised manuscript by Mar 13 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

José Antonio Ortega, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.   

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Well planned study design. The questionnaire is too long and may not be accepted by patients. Minor grammatical errors need correction.

Reviewer #2: This is a very that well-written and compelling study protocol.

I have only a few recommendations as described below:

Abstract

Line 32: It is not clear what “four” is referring to. Did you mean to state “four sessions”?

Background

Line 69: It seems more appropriate not label women with the term “infertile women” but rather describe them as “women with infertility.

Line 74: I would recommend changing “fertility help” to fertility assistance.

Line 88: Please enter a comma after “mental health”

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review.docx

PLoS One. 2022 Mar 11;17(3):e0264777. doi: 10.1371/journal.pone.0264777.r002

Author response to Decision Letter 0


16 Feb 2022

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have gone through the templates and made required changes to meet the journal requirements.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

2a. The data in the study are sensitive in nature. The contact details of the ethics review committee is given below:

Ethics Review Committee, Centre for Health Research and Development, Society for Applied Studies, 45, Kalu Sarai, New Delhi- 110016, India; Contact numbers: +919582595320; +917838350052; email ID: chrderc@sas.org.in

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

2b. This is not applicable as this is a protocol paper.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Supporting information files have been mentioned at the end of the manuscript including captions as desired.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

We have reviewed the references, these are complete and correct. To the best of our knowledge, none of the cited papers has been retracted.

Comments to the author

Reviewer #1: Well planned study design. The questionnaire is too long and may not be accepted by patients. Minor grammatical errors need correction.

Thank you very much for you comment, we agree with you. We have pretested the questionnaire for feasibility. Since we have a good rapport with the community, women in the community like to interact and share their experiences with us. If we feel at any point that the participant is reluctant to continue with data collection or is tired or has other commitments to fulfil, we will stop immediately and request for another day and time to continue with the data collection process. This may require multiple visits. We will ensure that administration of the questionnaire is according to the participants’ convenience.

Thank you for pointing out grammatical errors, we have corrected them.

Minor grammatical errors need correction

1. Abstract background line number 22 and 23- The sentence is not imparting a clear meaning as to what the author wants to convey.

Thank you for your comment, we have modified the sentence for greater clarity from line number 25 to27 and page number 2

2. Line number 118 - Modify sentence “women are not be under duress”

Thank you for pointing this out, we have now corrected it. Line number 121and page number 6

3. Line number 134 - All study documents are to be stored (to added)

Thank you for pointing this out, we have now corrected it. Line number 137and page number 7

4. Detailed questionnaire is not attached

We have now attached the detailed questionnaire as a supplement.

Reviewer #2: This is a very that well-written and compelling study protocol.

I have only a few recommendations as described below:

Abstract

Line 32: It is not clear what “four” is referring to. Did you mean to state “four sessions”?

Thank you for your comment. Four (4) refers to number of modules, each module having a set of questions that will be used in the study. The sentence has been modified for a clear understanding. Line number 34 and page number 2.

Background

Line 69: It seems more appropriate not label women with the term “infertile women” but rather describe them as “women with infertility.

We have changed from infertile women to women with infertility. Thank you again for such valuable feedback. Line number 72 and page number 4.

Line 74: I would recommend changing “fertility help” to fertility assistance.

We really appreciate for such insight. We have modified to fertility assistance. Line number 77 and page number 4

Line 88: Please enter a comma after “mental health”

Done, thank you. Line number 91 and page number 5

We hope we have addressed your comments satisfactorily and the manuscript will be considered for publication in the journal.

Decision Letter 1

José Antonio Ortega

17 Feb 2022

Characteristics, experiences and actions taken by women to address delayed conception: A mixed-methods cross-sectional study protocol

PONE-D-21-37261R1

Dear Dr. Mazumder,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

José Antonio Ortega, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The suggested changes have been addressed. Congratulations. Looking forward to the results.

Reviewers' comments:

Acceptance letter

José Antonio Ortega

28 Feb 2022

PONE-D-21-37261R1

Characteristics, experiences and actions taken by women to address delayed conception: A mixed-methods cross-sectional study protocol

Dear Dr. Mazumder:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. José Antonio Ortega

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. CHRD SAS ERC infertility approval letter.

    (PDF)

    S2 File. WHO ERC infertility approval letter.

    (PDF)

    S3 File. Consent form.

    (PDF)

    S1 Questionnaire. Questionnaire modules.

    (PDF)

    S1 Checklist. SPIRIT 2013 checklist: Recommended items to address in a clinical trial protocol and related documents*.

    (DOC)

    Attachment

    Submitted filename: Review.docx


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES